Lithium (low-dose) — The GSK-3 Inhibitor
Low-dose lithium is a trace mineral that acts as a potent neuroprotectant and cellular resilience enhancer. By inhibiting GSK-3 and upregulating the NRF2 antioxidant pathway, it promotes autophagy and stress resistance, making it a compelling candidate for slowing brain aging and extending healthspan.
Mechanism of Action
Lithium's primary mechanism of action involves the direct and indirect inhibition of glycogen synthase kinase-3 (GSK-3), a serine/threonine kinase that regulates numerous cellular processes. By inhibiting GSK-3, lithium prevents the phosphorylation and subsequent degradation of NRF2, allowing this transcription factor to translocate to the nucleus and upregulate antioxidant response elements (ARE). This hormetic stress response enhances cellular resilience against oxidative damage. Additionally, lithium induces autophagy by inhibiting inositol monophosphatase (IMPase), which lowers intracellular myo-inositol and IP3 levels, thereby promoting the clearance of aggregated proteins and damaged organelles.
Human Trial Evidence
Human evidence for low-dose lithium in longevity is limited but emerging, primarily focusing on neuroprotection. A 2013 randomized, double-blind trial in patients with Alzheimer's disease found that 300 micrograms/day of elemental lithium over 15 months prevented cognitive decline compared to placebo. Observational studies have also correlated trace levels of lithium in drinking water with reduced all-cause mortality and lower rates of dementia, though these are epidemiological associations rather than controlled longevity trials.
Dosing Protocol
Low-dose lithium is typically administered as lithium orotate or lithium aspartate at doses ranging from 1 to 5 mg of elemental lithium per day. This is orders of magnitude lower than psychiatric doses of lithium carbonate (600–1,200 mg/day). It is generally taken once daily. At these microdoses, prescription is not required in most jurisdictions, and therapeutic drug monitoring of serum lithium levels is typically unnecessary.
Safety & Contraindications
At microdoses (1–5 mg/day), lithium is generally well-tolerated with a high safety profile, avoiding the renal and thyroid toxicities associated with high-dose psychiatric use. However, individuals with pre-existing kidney disease or thyroid dysfunction should exercise caution and consult a physician. It may interact with diuretics, ACE inhibitors, and NSAIDs, which can alter lithium clearance even at low doses. Pregnant or breastfeeding women should avoid supplementation due to a lack of safety data at these dosages.